MARABETI, Maria Rita
 Distribuzione geografica
Continente #
NA - Nord America 4.362
EU - Europa 2.696
AS - Asia 2.135
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 171
AF - Africa 94
Totale 9.782
Nazione #
US - Stati Uniti d'America 4.244
SG - Singapore 746
RU - Federazione Russa 563
CN - Cina 530
FI - Finlandia 496
UA - Ucraina 348
IT - Italia 336
DE - Germania 256
BR - Brasile 251
HK - Hong Kong 216
VN - Vietnam 216
PL - Polonia 154
IE - Irlanda 125
GB - Regno Unito 119
FR - Francia 116
JP - Giappone 91
SE - Svezia 67
KR - Corea 59
IN - India 58
BD - Bangladesh 55
CA - Canada 48
CI - Costa d'Avorio 35
RO - Romania 31
MX - Messico 28
IQ - Iraq 27
BE - Belgio 24
NL - Olanda 20
CO - Colombia 19
AR - Argentina 18
TR - Turchia 18
PK - Pakistan 17
CR - Costa Rica 14
KE - Kenya 14
UZ - Uzbekistan 14
ZA - Sudafrica 13
ID - Indonesia 12
EC - Ecuador 11
IR - Iran 9
JM - Giamaica 9
MY - Malesia 9
PH - Filippine 9
VE - Venezuela 9
ES - Italia 8
CL - Cile 7
EG - Egitto 7
ET - Etiopia 7
MA - Marocco 7
TW - Taiwan 7
NP - Nepal 6
CH - Svizzera 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
AZ - Azerbaigian 4
BG - Bulgaria 4
BH - Bahrain 4
GR - Grecia 4
LB - Libano 4
LT - Lituania 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
TN - Tunisia 4
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
MD - Moldavia 3
PE - Perù 3
PR - Porto Rico 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
KZ - Kazakistan 2
NG - Nigeria 2
NI - Nicaragua 2
UY - Uruguay 2
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
MM - Myanmar 1
MU - Mauritius 1
PA - Panama 1
RS - Serbia 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.615
Città #
Ashburn 534
Singapore 503
San Jose 350
Woodbridge 254
Hong Kong 207
Fairfield 197
Jacksonville 195
Ann Arbor 180
Chandler 157
Houston 140
Wilmington 139
Zgierz 125
Dublin 124
Beijing 102
Dallas 101
Medford 97
Santa Clara 97
Council Bluffs 92
Des Moines 91
Moscow 88
Tokyo 85
Seattle 78
Frankfurt am Main 77
Nanjing 73
Los Angeles 67
Ho Chi Minh City 64
The Dalles 64
Princeton 63
Cambridge 60
Hanoi 59
Tulsa 54
Lauterbourg 52
New York 50
Dearborn 43
Helsinki 41
Buffalo 40
Hefei 39
Palermo 37
Abidjan 35
Boardman 31
Chicago 27
São Paulo 26
Milan 25
Venice 25
Brussels 24
Nanchang 23
London 22
Shenyang 21
San Diego 20
Changsha 19
Ludwigshafen am Rhein 19
Warsaw 19
Jiaxing 18
Munich 16
Tianjin 15
Verona 15
Hebei 14
Saint Petersburg 14
Da Nang 13
Jinan 13
Seoul 13
Amsterdam 12
Columbus 12
Montreal 12
Nairobi 12
Baghdad 11
Denver 11
Haiphong 11
City of London 10
Mexico City 10
Orem 10
Phoenix 10
San José 10
Tashkent 10
Altamura 9
Hangzhou 9
Lawrence 9
Toronto 9
Berlin 8
Bogotá 8
Bremen 8
Chennai 8
Marlborough 8
Philadelphia 8
Redondo Beach 8
Rome 8
Addis Ababa 7
Düsseldorf 7
Johannesburg 7
Kitzingen 7
Kumar 7
Paris 7
Seongnam 7
Taipei 7
Auburn Hills 6
Biên Hòa 6
Brooklyn 6
Charlotte 6
Frankfurt 6
Kingston 6
Totale 5.619
Nome #
Multiple changes induced by fibroblasts on breast cancer cells. 282
Differential occurrence of S100A7 in breast cancer tissues: A proteomic-based investigation 270
Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non-tumoral adjacent counterparts. 254
Breast cancer cells exhibit selective modulation induced by different collagen substrates. 250
Anti-oncogenic role of decorin: identification of new markers. 239
Large-scale proteomic identification of S100 proteins in breast cancer tissues. 229
Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines. 225
COMPARATIVE PROTEOMIC PROFILING OF NORMAL AND BREAST CANCER CELLS UNDER HYPOXIC CONDITIONS 217
CIRCULATING AND TISSUE FORMS OF MMP2 AND MMP9 IN BREAST CANCER PROGRESSION 217
A combined determination of circulating gelatinases and inflammatory markers in breast cancer patients during therapeutic treatment 216
Breast cancer proteomics: from research to clinical applications. 204
Cytoskeleton and Proteomic Changes Induced by Fibroblasts on Breast Cancer Cells 193
Fibroblast’s role in breast cancer: a proteomic approach 192
New Insights into the Occurrence of Matrix Metalloproteases -2 and -9 in a Cohort of Breast Cancer Patients and Proteomic Correlations 192
Comparative proteomics of breast cancer surgical tissues 182
Circulating levels of Matrix Metalloproteinases (MMP-2 and MMP-9), CRP and IL-6 during therapeutic treatment of patients with breast cancer 178
Comparative detection of matrix metalloproteinase-2 and -9, interleukin-6 and c-reactive protein in breast cancer serum of patients during neoadjuvant chemotherapy 175
S-100 calcium binding proteins as potential markers for breast cancer metastasis. 175
Fibroblasts enhance proliferation and invasion of Breast Cancer Cells (8701-BC) 170
Differential proteomics of thyroid carcinoma cell lines 169
Proteomic Detection of Breast-Cancer Subpopulation 166
New insight on genomic and proteomic profiling of decorin-transfected breast cancer cells. 165
Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer 165
DIFFERENTIAL PROTEOMIC ANALYSIS OF THYROID CARCINOMA CELL LlNES 164
Correlation between MMPS and proteomic profiles of breast cancer tissues 162
Herceptin-resistance in breast cancer cells: a proteomic study. 159
Evaluation of cellular response of breast cancer cells grown on distinctive collagen substrates 159
Matrix metalloproteases monitoring during neoadjuvant breast cancer therapy. An ongoing study. 152
Gene ontology-based annotation and comparative analysis of proteins extracted from proteomics of 100 breast cancer patients. 151
Differential proteomic and phenotypic behavior of papillary and anaplastic thyroid carcinoma cell lines: an updated study 148
Analisi comparativa tra linee cellulari di carcinoma tiroideo papillare ed anaplastico 147
Fibroblast’s influence on breast cancer cells. 144
Proteomic Detection of Breast-Cancer Subpopulations. 141
Different collagen substrates induce the expression of alternative forms of keratins and vimentin in breast cancer cells. 138
Occurrence of S100A7 in a large sample-set of breast cancer tissues 138
AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH 138
Cross-talk between breast cancer cells and fibroblasts in coculture system. 137
Levels of circulating gelatinases and proteomic correlations in breast cancer patients. 137
Herceptin-resistance in breast cancer cells: a proteomic approach 136
LARGE-SCALE COMPARATIVE PROTEOMICS OF BREAST CANCER SURGICAL TISSUES 136
Proteomic detection of S100 proteins in breastcancer tissues 134
Zymographic detection of MMP-2 and MMP-9 in breast cancer sera patients during chemotherapy. 133
S100S PROTEIN EXPRESSION IN A LARGE SAMPLE-SET OF BREAST CANCER TISSUES 132
PROTEOMIC MODULATION IN BREAST CANCER CELLS INDUCED BY MICROENVIRONMENT COMPONENTS 131
Large-scale comparative proteomics of breast surgical tissues 128
Identificazione di forme multiple di cheratine 8, 18 e vimentina espresse da cellule di carcinoma mammario coltivate su differenti substrati collagene 127
The fibroblasts: co-actors in cancer. 126
IDENTIFICATION OF TYPE V COLLAGEN-BINDING PROTEINS IN 8701-BC BREAST CANCER CELLS 123
EFFETTI DEL TRASTUZUMAB SUL PROTEOMA DI CELLULE DI CARCINOMA MAMMARIO OVER-ESPRIMENTI HER-2 122
Proteomic profiling of Trastuzumab (Herceptin(R))-sensitive and -resistant SKBR-3 breast cancer cells. 113
Identification of multiple forms of keratins expressed by brest cancer cells coltured on different collagen substrates. 112
Proteomic discovery of new differentiation markers in the U937 cell line 112
LARGE-SCALE SCREENING OF MATRIX METALLOPROTEINASES IN BREAST CANCER PATIENTS AND CLINICAL-MOLECULAR CORRELATIONS 111
Permissive and restrictive influences from breast cancer stroma 111
MMP-2, MMP-9 and MMP-14 in breast cancer: clinicopathological correlations. 108
Identification of multiple forms of keratins expressed by breast cancer cells coltured on different collagen substrates. 107
The challenge of tumor microenvironment 102
Proteomic approach to characterize homozygous Citrus clementina Hort. ex Tan. Genotypes 101
Proteomic analysis of Herceptin-resistance breast cancer cells 98
Proteomica comparata di un frammento chirurgico di carcinoma del colon e della metastasi epatica associata 96
Urinary Proteomic Profile Of A Multiple Myeloma Affected Patient 88
PROTEOMIC SIGNATURE OF BREAST CANCER TISSUES FOR PATIENTS STRATIFICATION 83
Prognostic and functional significant of mmp2 and mmp9 in breast cancer unveiled by proteomic analysis 72
Totale 9.782
Categoria #
all - tutte 31.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022390 0 0 2 5 17 20 12 28 67 97 17 125
2022/2023628 100 43 8 58 70 128 64 33 87 12 20 5
2023/2024387 17 66 15 77 36 72 39 6 0 6 6 47
2024/20251.018 22 110 69 74 49 16 73 39 65 89 176 236
2025/20263.611 299 80 216 248 358 440 437 391 309 582 104 147
2026/2027593 176 153 264 0 0 0 0 0 0 0 0 0
Totale 9.782